Warning letter
Novartis Animal Health Services AG: warning letter of Nov 29, 2004
FDA warning letter UCM146688 · Atlanta District Office
Key facts
| Reference number | UCM146688 |
|---|---|
| Company | Novartis Animal Health Services AG |
| Subject | Adverse Drug Experience Reporting Requirements |
| Issue date | Nov 29, 2004 |
| Posted date | Nov 29, 2004 |
| Issuing office | Atlanta District Office |
| Product type | Drugs |
| CFR sections cited | 514.3, 514.80(b)(1), 514.80(b)(2), 514.80(b)(2)(ii), 514.80(b)(4)(iv) |
| Country | 3 |
| Inspection city | Greensboro |
| Inspection ZIP | 27408-7611 |
| Inspection start date | Jan 20, 2004 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: